RMD · 8-K · 20260806PR337962

Liquidity and Debt Position

RESMED INC · 2026-08-06 · Importance 52 · Surprise 30 · No source text

Cash and cash equivalents increased to $1,469.2 million at June 30, 2026, from $1,209.5 million a year earlier. Total debt increased to $659.4 million, comprising $260.0 million of short-term debt and $399.4 million of long-term debt, compared with $668.3 million at June 30, 2025. Accounts receivable increased to $1,036.2 million and inventories increased to $945.8 million. Assets held for sale totaled $457.4 million and liabilities held for sale totaled $41.2 million at fiscal year-end.

Key facts

• Cash and cash equivalents at June 30, 2026: $1,469,234 thousand; at June 30, 2025: $1,209,450 thousand source
• Total assets at June 30, 2026: $8,965,950 thousand; total liabilities at June 30, 2026: $2,380,557 thousand; total stockholders’ equity at June 30, 2026: $6,585,393 thousand source
• Inventory at June 30, 2026: $945,805 thousand vs $927,711 thousand at June 30, 2025 source
• Accounts receivable, net at June 30, 2026: $1,036,233 thousand vs $939,492 thousand at June 30, 2025 source
• Short-term debt at June 30, 2026: $259,950 thousand; short-term debt at June 30, 2025: $9,900 thousand source
• Long-term debt at June 30, 2026: $399,415 thousand; at June 30, 2025: $658,392 thousand source
• Net cash used in investing activities for three months ended June 30, 2026: $(383,651) thousand vs $(133,713) thousand prior year source
• Net cash provided by (used in) financing activities for three months ended June 30, 2026: $(263,164) thousand vs $(163,887) thousand prior year source

Impact estimates